NASDAQ:ALNY
Alnylam Pharmaceuticals Stock News
$150.47
-0.90 (-0.595%)
At Close: May 10, 2024
IPO Update: Freeline Therapeutics Proposes Terms For U.S. IPO (Pending:FRLN)
05:44pm, Monday, 03'rd Aug 2020
Freeline Therapeutics Holdings plc has filed to raise $125 million in a U.S. IPO.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company has submitted a clinical trial authorization (CTA) application to The Medicines an
Dyne Therapeutics Appoints Susanna High as Chief Operating Officer
12:00am, Monday, 03'rd Aug 2020
Dyne Therapeutics today announced that it has appointed Susanna High, MBA, as its chief operating officer.
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:33pm, Thursday, 30'th Jul 2020
Alnylam (ALNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biotech Bonanza - Second Half Outlook
08:24am, Tuesday, 28'th Jul 2020
Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
A Top Contender in the Race for a NASH Drug Drops Out
03:02pm, Thursday, 23'rd Jul 2020
French biotech Genfit, which had been expected to bring one of the first drugs to market to treat nonalcoholic steatohepatitis, said it is getting out of the race altogether.
Alnylam to Webcast Conference Call Discussing Second Quarter 2020 Financial Results
12:00pm, Thursday, 23'rd Jul 2020
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter ending June 30, 2020 on Thursday, Augu
Alnylam’s Anant Murthy on making it as a US biotech in Europe -
09:50am, Monday, 20'th Jul 2020
Alnylam’s European head of market access and GM of mid-size markets, Anant Murthy, shares his perspective on how a US biotech can adapt to the many unique challenges of the EU market
SQZ Biotech Appoints Paul Bolno, MD to Board of Directors and Kai Wucherpfennig, MD, PhD to Scientific Advisory Board
12:00am, Monday, 20'th Jul 2020
SQZ Biotechnologies (SQZ), a clinical stage cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appoi
Morgan Stanley Increases Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $199.00
05:36am, Sunday, 19'th Jul 2020
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target increased by Morgan Stanley from $162.00 to $199.00 in a research report sent to investors on Wednesday, BenzingaRatingsTable reports. They c
Fauci says U.S. needs to 'get better control' of the coronavirus to reopen without outbreaks
05:43pm, Friday, 17'th Jul 2020
Dr. Anthony Fauci said Friday that the coronavirus has hit the U.S. "very severely" and the country "needs to get better control over things" in order to reopen the economy and head toward normality.
Steroid's COVID-19 benefits confirmed; spotlight on immune cells
12:00am, Friday, 17'th Jul 2020
Steroid's COVID-19 benefits confirmed; spotlight on immune cells
